These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
180 related articles for article (PubMed ID: 38014983)
1. Pharmacokinetics and safety evaluation of intravenously administered Wang S-y; Tan X; Liu Z-q; Ma H; Liu T-b; Yang Y-q; Ying Y; Gao R-y; Zhang D-z; Ma Y-f; Chen K; Lin L; Jiang Z-h; Yu J-l Microbiol Spectr; 2024 Jan; 12(1):e0188223. PubMed ID: 38014983 [TBL] [Abstract][Full Text] [Related]
2. Isolation and Characterization of Three Pseudomonas aeruginosa Viruses with Therapeutic Potential. Wang X; Tang J; Dang W; Xie Z; Zhang F; Hao X; Sun S; Liu X; Luo Y; Li M; Gu Y; Wang Y; Chen Q; Shen X; Xu L Microbiol Spectr; 2023 Jun; 11(3):e0463622. PubMed ID: 37125933 [TBL] [Abstract][Full Text] [Related]
3. Two Novel Bacteriophages Improve Survival in Jeon J; Yong D Appl Environ Microbiol; 2019 May; 85(9):. PubMed ID: 30824445 [TBL] [Abstract][Full Text] [Related]
7. Alginate microbeads and hydrogels delivering meropenem and bacteriophages to treat Pseudomonas aeruginosa fracture-related infections. Chen B; Benavente LP; Chittò M; Wychowaniec JK; Post V; D'Este M; Constant C; Zeiter S; Feng W; Moreno MG; Trampuz A; Wagemans J; Onsea J; Richards RG; Lavigne R; Moriarty TF; Metsemakers WJ J Control Release; 2023 Dec; 364():159-173. PubMed ID: 37866403 [TBL] [Abstract][Full Text] [Related]
8. Optimized preparation pipeline for emergency phage therapy against Pseudomonas aeruginosa at Yale University. Würstle S; Lee A; Kortright KE; Winzig F; An W; Stanley GL; Rajagopalan G; Harris Z; Sun Y; Hu B; Blazanin M; Hajfathalian M; Bollyky PL; Turner PE; Koff JL; Chan BK Sci Rep; 2024 Feb; 14(1):2657. PubMed ID: 38302552 [TBL] [Abstract][Full Text] [Related]
9. Successful Use of Phage and Antibiotics Therapy for the Eradication of Two Bacterial Pathogens from the Respiratory Tract of an Infant. Morozova VV; Kozlova YN; Tikunova NV Methods Mol Biol; 2024; 2734():237-243. PubMed ID: 38066373 [TBL] [Abstract][Full Text] [Related]
10. Improving the Inhibitory Effect of Phages against Aghaee BL; Khan Mirzaei M; Alikhani MY; Mojtahedi A; Maurice CF Viruses; 2021 Feb; 13(2):. PubMed ID: 33670028 [TBL] [Abstract][Full Text] [Related]
11. Bacteriophages φMR299-2 and φNH-4 can eliminate Pseudomonas aeruginosa in the murine lung and on cystic fibrosis lung airway cells. Alemayehu D; Casey PG; McAuliffe O; Guinane CM; Martin JG; Shanahan F; Coffey A; Ross RP; Hill C mBio; 2012; 3(2):e00029-12. PubMed ID: 22396480 [TBL] [Abstract][Full Text] [Related]
13. Phage Therapy Is Effective in a Mouse Model of Bacterial Equine Keratitis. Furusawa T; Iwano H; Hiyashimizu Y; Matsubara K; Higuchi H; Nagahata H; Niwa H; Katayama Y; Kinoshita Y; Hagiwara K; Iwasaki T; Tanji Y; Yokota H; Tamura Y Appl Environ Microbiol; 2016 Sep; 82(17):5332-9. PubMed ID: 27342558 [TBL] [Abstract][Full Text] [Related]
14. Utility of lytic bacteriophage in the treatment of multidrug-resistant Pseudomonas aeruginosa septicemia in mice. Vinodkumar CS; Kalsurmath S; Neelagund YF Indian J Pathol Microbiol; 2008; 51(3):360-6. PubMed ID: 18723958 [TBL] [Abstract][Full Text] [Related]
15. Engineered Bacteriophages Containing Anti-CRISPR Suppress Infection of Antibiotic-Resistant P. aeruginosa. Qin S; Liu Y; Chen Y; Hu J; Xiao W; Tang X; Li G; Lin P; Pu Q; Wu Q; Zhou C; Wang B; Gao P; Wang Z; Yan A; Nadeem K; Xia Z; Wu M Microbiol Spectr; 2022 Oct; 10(5):e0160222. PubMed ID: 35972246 [TBL] [Abstract][Full Text] [Related]
16. Studying Bacteriophage Efficacy Using a Zebrafish Model. Cafora M; Brix A; Forti F; Briani F; Pistocchi A Methods Mol Biol; 2024; 2734():151-169. PubMed ID: 38066368 [TBL] [Abstract][Full Text] [Related]
17. Bacteriophage PEV20 and Ciprofloxacin Combination Treatment Enhances Removal of Pseudomonas aeruginosa Biofilm Isolated from Cystic Fibrosis and Wound Patients. Chang RYK; Das T; Manos J; Kutter E; Morales S; Chan HK AAPS J; 2019 Apr; 21(3):49. PubMed ID: 30949776 [TBL] [Abstract][Full Text] [Related]
18. Efficacy and tolerability of a cocktail of bacteriophages to treat burn wounds infected by Pseudomonas aeruginosa (PhagoBurn): a randomised, controlled, double-blind phase 1/2 trial. Jault P; Leclerc T; Jennes S; Pirnay JP; Que YA; Resch G; Rousseau AF; Ravat F; Carsin H; Le Floch R; Schaal JV; Soler C; Fevre C; Arnaud I; Bretaudeau L; Gabard J Lancet Infect Dis; 2019 Jan; 19(1):35-45. PubMed ID: 30292481 [TBL] [Abstract][Full Text] [Related]
19. Phage ΦPan70, a Putative Temperate Phage, Controls Pseudomonas aeruginosa in Planktonic, Biofilm and Burn Mouse Model Assays. Holguín AV; Rangel G; Clavijo V; Prada C; Mantilla M; Gomez MC; Kutter E; Taylor C; Fineran PC; Barrios AF; Vives MJ Viruses; 2015 Aug; 7(8):4602-23. PubMed ID: 26274971 [TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics and Time-Kill Study of Inhaled Antipseudomonal Bacteriophage Therapy in Mice. Chow MYT; Chang RYK; Li M; Wang Y; Lin Y; Morales S; McLachlan AJ; Kutter E; Li J; Chan HK Antimicrob Agents Chemother; 2020 Dec; 65(1):. PubMed ID: 33077657 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]